FMR LLC reported beneficial ownership of 2,173,126.20 shares of PHIBRO ANIMAL HEALTH CORP Class A common stock, representing 10.5% of the class as of 03/31/2026. The filing states FMR has sole voting power over 2,171,187 shares and sole dispositive power over 2,173,126.20 shares. The Schedule 13G notes some shares are held on behalf of other persons and refers to Exhibit 99 for a 13d-1(k)(1) agreement.
Positive
None.
Negative
None.
Insights
Passive investor reporting a >5% stake in PHIBRO Animal Health.
FMR LLC reports beneficial ownership of 2,173,126.20 shares (10.5%) with sole dispositive control. The Schedule 13G filing characterizes the holding as passive under applicable rules and lists voting and dispositive powers clearly.
Watch subsequent filings for any conversion to an active 13D or Form 4 disclosures; the excerpt references an associated 13d-1(k)(1) agreement in Exhibit 99, which may detail any special arrangements.
Key Figures
Beneficial ownership:2,173,126.20 sharesPercent of class:10.5%Sole voting power:2,171,187 shares+4 more
7 metrics
Beneficial ownership2,173,126.20 sharesAmount beneficially owned as reported in Item 4
Percent of class10.5%Percent of Class A common stock as reported in Item 4
Sole voting power2,171,187 sharesSole power to vote reported on cover page
Sole dispositive power2,173,126.20 sharesSole power to dispose reported in Item 4
Reporting date03/31/2026Date associated with holdings disclosure
Filing signature date04/06/2026Date signatures were executed on the filing
CUSIP71742Q106Identifier for PHIBRO Animal Health Class A common stock
Key Terms
Schedule 13G, beneficially owned, sole dispositive power, 13d-1(k)(1) agreement
4 terms
Schedule 13Gregulatory
"Item 1. Name of issuer: PHIBRO ANIMAL HEALTH CORP"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially ownedfinancial
"Item 4. Amount beneficially owned: 2173126.20"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive powerfinancial
"Item 4. (iii) Sole power to dispose: 2173126.20"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
13d-1(k)(1) agreementregulatory
"Please see Exhibit 99 for 13d-1(k) (1) agreement"
What stake does FMR LLC report in PHIBRO Animal Health (PAHC)?
FMR LLC reports beneficial ownership of 2,173,126.20 shares, or 10.5% of the Class A stock. The filing lists sole dispositive power over 2,173,126.20 shares and sole voting power over 2,171,187 shares as of 03/31/2026.
Does the Schedule 13G indicate active control by FMR LLC?
The Schedule 13G characterizes the position as passive. It reports voting and dispositive powers but files as a 13G, which is used for passive investors rather than signaling an intent to influence control.
What voting and dispositive powers does FMR LLC hold for PAHC shares?
FMR LLC has sole voting power over 2,171,187 shares and sole dispositive power over 2,173,126.20 shares. Shared voting and dispositive powers are reported as 0.00 in the filing.
Is any third party identified as having rights to dividends or sale proceeds?
The filing states one or more other persons are known to have rights to dividends or sale proceeds, but no single other person holds more than 5%. Specific third parties are not listed in the excerpt.
Where can I find details of any agreement related to this holding?
The Schedule 13G refers to Exhibit 99 for a 13d-1(k)(1) agreement. That exhibit likely contains the identification/classification of the subsidiary or details of any related agreement; consult Exhibit 99 in the filing for specifics.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
PHIBRO ANIMAL HEALTH CORP
(Name of Issuer)
CLASS A COMMON STOCK
(Title of Class of Securities)
71742Q106
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
71742Q106
1
Names of Reporting Persons
FMR LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
2,171,187.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
2,173,126.20
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,173,126.20
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.5 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
71742Q106
1
Names of Reporting Persons
Abigail P. Johnson
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
2,173,126.20
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,173,126.20
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.5 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
PHIBRO ANIMAL HEALTH CORP
(b)
Address of issuer's principal executive offices:
GLENPOINTE CENTRE EAST, 3RD FLOOR,300 FRANK W. BURR BLVD., SUITE 21,TEANECK,NJ,USA,07666
Item 2.
(a)
Name of person filing:
FMR LLC
(b)
Address or principal business office or, if none, residence:
245 Summer Street, Boston, Massachusetts 02210
(c)
Citizenship:
Not applicable
(d)
Title of class of securities:
CLASS A COMMON STOCK
(e)
CUSIP Number(s):
71742Q106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
2173126.20
(b)
Percent of class:
10.5 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Please see the responses to Items 5 and 6 on the cover page.
(ii) Shared power to vote or to direct the vote:
0.00
(iii) Sole power to dispose or to direct the disposition of:
2173126.20
(iv) Shared power to dispose or to direct the disposition of:
0.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of PHIBRO ANIMAL HEALTH CORP. No one other person's interest in the CLASS A COMMON STOCK of PHIBRO ANIMAL HEALTH CORP is more than five percent of the total outstanding CLASS A COMMON STOCK.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See attached Exhibit 99.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
FMR LLC
Signature:
Stephanie J. Brown
Name/Title:
Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:
04/06/2026
Abigail P. Johnson
Signature:
Stephanie J. Brown
Name/Title:
Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:
04/06/2026
Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
